NeurAxis, Inc. (NRXS) Stock Forecast 2026: P10, P50 & P90 — Probabli.AI
Timestamped NRXS stock forecast with 1-year P10, P50, and P90 price estimates, scenario probabilities, definitions, sources, and limitations.
Direct answer: NeurAxis, Inc. has shown impressive short-term growth potential due to recent FDA approval and strategic partnerships. While some volatility and competition risks exist, the company's revenue trajectory and focus on transformative technology paint a strong growth picture for long-term investors. The saved 1-year distribution is P10 $6.2, P50 $11.2, and P90 $15.5.
Last analyzed · Model: gpt-4o
NeurAxis, Inc. Forecast data
| Estimate | 1-year price | Meaning |
|---|
| P10 | $6.2 | Pessimistic plausible scenario |
| P50 | $11.2 | Median scenario |
| P90 | $15.5 | Optimistic plausible scenario |
What the numbers mean
P10, P50, and P90 are model-generated scenario estimates: roughly a pessimistic plausible outcome, a median outcome, and an optimistic plausible outcome. They are not calibrated confidence intervals.
Supporting analysis
NeurAxis has shown impressive potential given its FDA approval and partnership announcement. The strong buy recommendation with a median target of $13 also highlights bullish sentiment, although the market still acknowledges risks related to competition and revenue consistency.
Sources and limitations
Market and company inputs are primarily sourced through Yahoo Finance and public financial-data interfaces. This page reports a saved AI-generated scenario analysis as of the timestamp above; it is not live data, audited probability, financial advice, or a guaranteed return.
Frequently asked questions
When was this NRXS analysis generated?
April 29, 2026.
Is this a guaranteed NRXS prediction?
No. It is a model-generated scenario assessment with material uncertainty.
View the full NRXS stock analysis · NRXS sentiment · Methodology · Accuracy & validation
The information on this page is for educational and informational purposes only and does not constitute professional financial advice.